xmlns:atom="http://www.w3.org/2005/Atom"
24. The fee for an application for a manufacturing authorisation for a veterinary medicinal product is £2,660.
25. The fee for an application to vary a manufacturing authorisation is £475 where the variation requires scientific or pharmaceutical assessment, and £165 where it does not.
26.—(1) The fee for an application for a standard authorisation to manufacture an autogenous vaccine or a veterinary medicinal product for administration under the cascade is £3,035 for each manufacturing site, with the same fee for each subsequent inspection.
(2) In the case of an application for an individual authorisation to manufacture a single batch of autogenous vaccine, or a single batch of veterinary medicinal product for administration under the cascade the fee is £1,515.
(3) The fee to vary an authorisation is £285 if no further inspection is required, and otherwise is the full application fee.
27.—(1) An annual fee of £245 is payable in respect of each manufacturing authorisation held (other than a manufacturing authorisation in relation to an autogenous vaccine or a veterinary medicinal product for administration under the cascade).
(2) The annual fee for a manufacturing authorisation for an autogenous vaccine or a veterinary medicinal product for administration under the cascade is 0.67% of the turnover in the previous calendar year rounded up to the next £1, with a minimum fee of £10, and in this paragraph “turnover” has the meaning given in paragraph 21(4).
28. For the purposes of deciding the fee for a site inspection—
“super site” is a site at which 250 or more relevant persons are employed;
“major site” is a site at which 60 or more, but fewer than 250, relevant persons are employed;
“standard site” is a site at which 10 or more, but fewer than 60 relevant persons are employed;
“minor site” is a site at which fewer than 10 relevant persons are employed;
“relevant person” means a person employed on the premises and systems inspected.
29. The fees for the inspection of a site where immunological veterinary medicinal products are manufactured are in accordance with the following table.
Type of site | Fee (£) |
---|---|
Super site: | 24,615 |
Major site: | 17,325 |
Standard site: | 5,570 |
Minor site: | 4,865 |
30. The following fees are payable for the inspection of a site where no immunological veterinary medicinal products are manufactured, but where sterile products are manufactured.
Type of site | Fee (£) |
---|---|
Super site: | 18,125 |
Major site: | 10,020 |
Standard site: | 4,925 |
Minor site: | 3,295 |
31. The following fees are payable for the inspection of a site where only non-immunological and non-sterile veterinary medicinal products are manufactured—
Type of site | Fee (£) |
---|---|
Super site: | 10,925 |
Major site: | 5,750 |
Standard site: | 4,125 |
Minor site: | 2,225 |
32. The following fees are payable for the inspection of a site where the only manufacturing process in relation to veterinary medicinal products is their assembly after the product has been put into its immediate container.
Type of site | Fee (£) |
---|---|
Super site: | 7,945 |
Major site: | 5,365 |
Standard site: | 2,635 |
Minor site: | 1,360 |
33. The fee for the inspection of a test site is £2,730.
34.—(1) The fee for an authorisation to operate a blood bank is £3,035, with the same fee for each subsequent inspection.
(2) The fee for a variation is £285.
35. In addition the travel and subsistence costs of the inspectors, and any additional costs reasonably incurred by them (including, in the case of an inspection outside the United Kingdom, interpreters' fees) are payable.